Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2001 Sep 18;165(6):786-8.

Sponsorship, authorship and accountability

Editorial

Sponsorship, authorship and accountability

F Davidoff et al. CMAJ. .
No abstract available

PubMed Disclaimer

Comment in

  • Ethics and industry-sponsored research.
    Loschiavo SR. Loschiavo SR. CMAJ. 2002 Mar 5;166(5):579; author reply 582. CMAJ. 2002. PMID: 11898931 Free PMC article. No abstract available.
  • Ethics and industry-sponsored research.
    Holmer AF. Holmer AF. CMAJ. 2002 Mar 5;166(5):580; author reply 582. CMAJ. 2002. PMID: 11898933 Free PMC article. No abstract available.
  • Ethics and industry-sponsored research.
    Pater JL, Parulekar W, O'Callagham C, Shepherd L, Eisenhouer E, Seymour L, Tu D, Ding K. Pater JL, et al. CMAJ. 2002 Mar 5;166(5):581-2. CMAJ. 2002. PMID: 11898934 Free PMC article. No abstract available.
  • Conforming to ICMJE principles.
    Halperin SA, Scheifele D, Duval B, Ward B. Halperin SA, et al. CMAJ. 2005 Nov 22;173(11):1358-9. doi: 10.1503/cmaj.1050172. CMAJ. 2005. PMID: 16301708 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Henderson L. More AMCs finding growth from reform. Centerwatch 2000;7(6):1,10-3.
    1. Kowalczyk L. Harvard, other medical schools aim to give drug firms faster pace for trials. Boston Globe 2000;Jul 28:C4.
    1. Mathieu MP. Parexel's pharmaceutical R&D sourcebook, 1998. Waltham (MA): Parexel International Corporation; 1999.
    1. Rennie D. Thyroid storm. JAMA 1997;277:1238-43. - PubMed
    1. Kahn JO, Weng D, Mayer K, Murray H, Lagakos S, for the 806 Investigator Team. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 х 106/L CD4 cell counts. JAMA 2000;284:2193-202. - PubMed

Publication types